Last updated: May 20, 2024
Sponsor: Saint Vincent's Hospital, Korea
Overall Status: Active - Recruiting
Phase
N/A
Condition
Biliary Tract Cancer
Gall Bladder Disorders
Treatment
wedge resection
bisegmentectomy
Clinical Study ID
NCT02920554
XC14EIMI0009V
Ages 19-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with T2 or T3 gallbladder cancer on preoperative CT exam
Patients who are pathologically diagnosed as T2 or T3 gallbladder cancer afterinitial simple cholecystectomy
Exclusion
Exclusion Criteria:
Peritoneal seeding or distant metastasis
Impossible to resect the cancer radically
Pathologically diagnosed to other malignancy such as adenosquamous carcinoma,sarcoma, etc.
R1 or R2 resection were pathologically diagnosed.
Study Design
Total Participants: 88
Treatment Group(s): 2
Primary Treatment: wedge resection
Phase:
Study Start date:
July 01, 2014
Estimated Completion Date:
December 31, 2030
Study Description
Connect with a study center
the Catholic University of Korea St. Vincent's Hospital
Suwon, 16247
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.